News Releases

News Release

Meridian Bioscience to Present at the Sidoti & Company, LLC Twelfth Annual New York Emerging Growth Institutional Investor Forum

March 25, 2008 at 8:31 AM EDT

CINCINNATI--(BUSINESS WIRE)--March 25, 2008--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that the Company has been invited to present at the Sidoti & Company, LLC Twelfth Annual New York Emerging Growth Institutional Investor Forum at The Hyatt Regency Hotel in New York. Jack Kraeutler, Chief Executive Officer, is scheduled to present on Wednesday, March, 26, 2008 at 1:30 p.m. ET. A question and answer session will follow and some of the information provided during the session may not have been previously disclosed. Mr. Kraeutler will be available to meet with investors during the Conference.

On March 26, 2008, the information presented at the Conference can be viewed on the Company's website,, under Events and Presentations on the Investors Relations page.

Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents, and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products and diagnostic tests provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, and respiratory infections. Meridian's diagnostic products are used outside of the human body and require little or no special equipment. The Company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology, and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents, specialty biologicals, and related technologies used by biopharmaceutical companies engaged in research for new drugs and vaccines. The Company markets its products and technologies to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers and biotech companies in more than 60 countries around the world. The Company's shares are traded through NASDAQ's Global Select Market, symbol VIVO. Meridian's website address is

CONTACT: Meridian Bioscience, Inc.
John A. Kraeutler, Chief Executive Officer, 513-271-3700

SOURCE: Meridian Bioscience, Inc.